INVX vs. ACA
INVX (Innovex International, Inc) and ACA (Arcosa, Inc.) are both stocks. INVX operates in Oil & Gas Equipment & Services (Energy), while ACA operates in Infrastructure Operations (Industrials). Over the past 5 years, INVX returned -7.15%/yr vs 19.80%/yr for ACA. At a 0.37 correlation, their price movements are largely independent.
Performance
INVX vs. ACA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, INVX achieves a 17.28% return, which is significantly lower than ACA's 35.88% return.
INVX
- 1D
- -0.04%
- 1M
- -14.64%
- YTD
- 17.28%
- 6M
- 14.82%
- 1Y
- 70.09%
- 3Y*
- 4.73%
- 5Y*
- -7.15%
- 10Y*
- -8.13%
ACA
- 1D
- -0.40%
- 1M
- 19.54%
- YTD
- 35.88%
- 6M
- 30.29%
- 1Y
- 64.31%
- 3Y*
- 26.62%
- 5Y*
- 19.80%
- 10Y*
- —
INVX vs. ACA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
INVX Innovex International, Inc | 17.28% | 56.55% | -39.97% | -14.35% | 38.06% | -33.56% | -36.86% | 56.21% | -28.19% |
ACA Arcosa, Inc. | 35.88% | 10.15% | 17.34% | 52.54% | 3.51% | -3.73% | 23.87% | 61.89% | -7.70% |
Correlation
The correlation between INVX and ACA is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.18 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.26 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.31 |
Correlation (All Time) Calculated using the full available price history since Oct 30, 2018 | 0.37 |
The correlation between INVX and ACA shifts across timeframes, from 0.18 (1 year) to 0.37 (all time), reflecting how their relationship changes across market environments.
Fundamentals
INVX:
$1.77B
ACA:
$7.10B
INVX:
$0.75
ACA:
$4.54
INVX:
34.24
ACA:
31.82
INVX:
0.10
ACA:
0.43
INVX:
1.82
ACA:
2.51
INVX:
1.72
ACA:
2.70
INVX:
$976.87M
ACA:
$2.82B
INVX:
$280.46M
ACA:
$642.70M
INVX:
$157.28M
ACA:
$460.00M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
INVX vs. ACA — Risk / Return Rank
INVX
ACA
INVX vs. ACA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Innovex International, Inc (INVX) and Arcosa, Inc. (ACA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| INVX | ACA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.07 | ||
| Sortino ratioReturn per unit of downside risk | -0.13 | ||
| Omega ratioGain probability vs. loss probability | 1.28 | 1.34 | -0.06 |
| Calmar ratioReturn relative to maximum drawdown | 3.93 | 3.01 | +0.92 |
| Martin ratioReturn relative to average drawdown | 9.30 | 8.89 | +0.41 |
Loading charts...
Drawdowns
INVX vs. ACA - Drawdown Comparison
The maximum INVX drawdown since its inception was -89.50%, which is greater than ACA's maximum drawdown of -36.79%. Use the drawdown chart below to compare losses from any high point for INVX and ACA.
Loading charts...
Drawdown Indicators
| INVX | ACA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -89.50% | -36.79% | -52.71% |
Max Drawdown (1Y)Largest decline over 1 year | -17.91% | -21.45% | +3.54% |
Max Drawdown (3Y)Largest decline over 3 years | -58.93% | -36.63% | -22.30% |
Max Drawdown (5Y)Largest decline over 5 years | -68.88% | -36.63% | -32.25% |
Max Drawdown (10Y)Largest decline over 10 years | -81.31% | — | — |
Current DrawdownCurrent decline from peak | -78.51% | -0.40% | -78.11% |
Average DrawdownAverage peak-to-trough decline | -45.43% | -11.44% | -33.99% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.56% | 7.26% | +0.30% |
Volatility
INVX vs. ACA - Volatility Comparison
Innovex International, Inc (INVX) has a higher volatility of 16.14% compared to Arcosa, Inc. (ACA) at 10.41%. This indicates that INVX's price experiences larger fluctuations and is considered to be riskier than ACA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| INVX | ACA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.14% | 10.41% | +5.73% |
Volatility (6M)Calculated over the trailing 6-month period | 30.81% | 28.86% | +1.95% |
Volatility (1Y)Calculated over the trailing 1-year period | 42.06% | 36.75% | +5.31% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 46.41% | 34.62% | +11.79% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 46.67% | 42.06% | +4.61% |
Dividends
INVX vs. ACA - Dividend Comparison
INVX has not paid dividends to shareholders, while ACA's dividend yield for the trailing twelve months is around 0.14%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
ACA Arcosa, Inc. | 0.14% | 0.19% | 0.21% | 0.24% | 0.37% | 0.38% | 0.36% | 0.45% |
INVX Innovex International, Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
INVX vs. ACA - Financials Comparison
This section allows you to compare key financial metrics between Innovex International, Inc and Arcosa, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
INVX vs. ACA - Profitability Comparison
INVX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Innovex International, Inc reported a gross profit of 84.51M and revenue of 239.03M. Therefore, the gross margin over that period was 35.4%.
ACA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Arcosa, Inc. reported a gross profit of 120.90M and revenue of 571.70M. Therefore, the gross margin over that period was 21.2%.
INVX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Innovex International, Inc reported an operating income of -21.83M and revenue of 239.03M, resulting in an operating margin of -9.1%.
ACA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Arcosa, Inc. reported an operating income of -2.00M and revenue of 571.70M, resulting in an operating margin of -0.4%.
INVX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Innovex International, Inc reported a net income of -16.67M and revenue of 239.03M, resulting in a net margin of -7.0%.
ACA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Arcosa, Inc. reported a net income of 37.80M and revenue of 571.70M, resulting in a net margin of 6.6%.
Frequently Asked Questions
INVX and ACA have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
INVX has higher volatility (16.14%) compared to ACA (10.41%). In terms of maximum drawdown, INVX dropped -89.50% vs ACA's -36.79%.
ACA currently has the higher Sharpe Ratio (1.76 vs 1.69), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for INVX and ACA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer